300016 北陆药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.2780.823-4.1880.6216.975
总资产报酬率 ROA (%)1.4250.471-2.5450.3944.364
投入资产回报率 ROIC (%)1.6090.529-2.8260.4434.958

边际利润分析
销售毛利率 (%)45.87347.67447.00855.39062.270
营业利润率 (%)5.250-0.061-11.276-1.73414.789
息税前利润/营业总收入 (%)9.2325.198-6.3883.55417.415
净利润/营业总收入 (%)4.5220.027-9.341-0.59412.826

收益指标分析
经营活动净收益/利润总额(%)72.849-332.39156.298165.68871.042
价值变动净收益/利润总额(%)26.641585.4507.873-139.15422.088
营业外收支净额/利润总额(%)-1.85223.9900.70810.020-3.938

偿债能力分析
流动比率 (X)2.2212.5733.3323.8924.574
速动比率 (X)1.6111.7772.6502.9793.698
资产负债率 (%)26.47038.55736.64331.76628.173
带息债务/全部投入资本 (%)19.46732.97231.74827.09124.883
股东权益/带息债务 (%)396.525192.592204.874258.021292.957
股东权益/负债合计 (%)259.271145.255159.771198.395226.957
利息保障倍数 (X)2.2640.985-1.2850.6485.466

营运能力分析
应收账款周转天数 (天)59.39965.02758.85656.39063.644
存货周转天数 (天)208.588212.280198.714277.242203.681